Ki Chung to Bevacizumab
This is a "connection" page, showing publications Ki Chung has written about Bevacizumab.
Connection Strength
0.109
-
Phase I study of two schedules of oral S-1 in combination with fixed doses of oxaliplatin and bevacizumab in patients with advanced solid tumors. Oncology. 2011; 81(2):65-72.
Score: 0.092
-
Bevacizumab 5 mg/kg can be infused safely over 10 minutes. J Clin Oncol. 2007 Jul 01; 25(19):2691-5.
Score: 0.017